{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03743155",
      "OrgStudyIdInfo": {
        "OrgStudyId": "XRS-ITRT-2018"
      },
      "Organization": {
        "OrgFullName": "Institut de Terapia Regenerativa Tissular",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy",
      "OfficialTitle": "Phase II Clinical Trial to Evaluate the Effect and Safety of MSV * in Xerostomia * Adult Autologous Bone Marrow Mesenchymal Stem Cells, Expanded Under GMP of IBGM"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2018",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "December 15, 2018",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "May 30, 2019",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "May 30, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "November 5, 2018",
      "StudyFirstSubmitQCDate": "November 14, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 16, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "November 14, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "November 16, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Institut de Terapia Regenerativa Tissular",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Phase II not controlled, open-label, prospective, single center clinical trial",
      "DetailedDescription": "Determine changes in the xerostomia characteristics and discomfort degree by means of questionnaires addressed to the physician and subject of study.\nDetermine the volume of submaxilar saliva without stimulation and with stimulation by sialometry (SL).\nDetect changes in volume, vascularization and fibrosis of submaxillary glands based on magnetic resonance imaging (MRI) with contrast.\nDetect changes of submaxillary gland functionalism based on Gammagraphy (GF)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Xerostomia Due to Radiotherapy"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignInterventionModelDescription": "single arm due to not alternative treatment exist",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "10",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "treatment with mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "xerostomy using mesenchymal stem cells adult autologous bone marrow",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: mesenchymal cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "mesenchymal cells",
            "InterventionDescription": "Autologous bone marrow aspiration is used as a cellular source to obtain MSVs and is subjected to the protocolized anticoagulant procedure. After checking the perfect condition of the shipment and the correct completion of the documentation that accompanies it, the processing of the bone marrow will be carried out. The processing of the bone marrow will be done in the Cell Therapy Unit of the IBGM under NCF, within 24 hours of the completion of the aspiration",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "treatment with mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Changes in the characteristics and degree of discomfort of xerostomia trough OHIP questionnaire",
            "PrimaryOutcomeDescription": "Absolute and relative change of the score of the OHIP Questionnaire (OHIP-14-sp)",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Changes in the characteristics and degree of discomfort of xerostomia.",
            "PrimaryOutcomeDescription": "Absolute and relative change of the score of the EVA Questionnaire",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Sialometry results",
            "PrimaryOutcomeDescription": "Absolute and relative change in the volume of saliva (ml / min) submaxillary",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Restoration of the glandular structure.",
            "PrimaryOutcomeDescription": "Changes in the glandular structure (volume) (MRI with contrast)",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Restoration of the glandular structure.",
            "PrimaryOutcomeDescription": "Changes in the glandular structure (vascularization) (MRI with contrast)",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Restoration of the glandular structure.",
            "PrimaryOutcomeDescription": "Changes in the glandular structure (fibrosis of submaxillary glands) (MRI with contrast)",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Measurement of submaxillary gland functionalism changes based on Gammagraphy",
            "PrimaryOutcomeDescription": "Measurement of submaxillary gland functionalism changes based on Gammagraphy",
            "PrimaryOutcomeTimeFrame": "24 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "AEs and SAEs",
            "SecondaryOutcomeDescription": "Determination of the Safety of the proposed procedure, recording adverse events (AEs) and serious adverse events (SAEs). It will be considered as early safety measures: Pain at the site of injection, submaxillary swelling, duration of submaxillary swelling in days, oral discomfort, infection",
            "SecondaryOutcomeTimeFrame": "24 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients from 18 to 75 years old of both sexes.\nBiochemical analysis without significant alterations which could contraindicate the treatment.\nBilateral radiotherapy of the previous neck due to neoplasia in states T1-T2 and N0, N1 and N2a.\n2 years of follow-up without recurrence.\nReduction of salivation and hyposalivation, evaluated by an examination, flow rate or whole unstimulated saliva in the range of 0.05- 0.20 ml / min.\nGrade 1-3 xerostomy as assessed by the grading scale.\nThe patient is able to understand the nature of the study.\nWritten informed consent of the patient\n\nExclusion Criteria:\n\nParticipation in another clinical trial in the 3 months prior to his/her inclusion.\nPresent infection (no infectious sign should be evidenced with repercussion on the evolution of the treated lesion).\nPatients with positive serologies for HIV, lues and hepatitis with positive viral load.\nHistory of cancer in the last 2 years. History of teratoma, adenocarcinoma derived from one of the salivary glands, lymphoma of the tonsils or some other lymphatic tissue or melanoma of pigmented cells of the oral mucosa.\nXerogenic medication in progress.\nOther diseases of the salivary glands, for example, Sj√∂gren's syndrome, sialolithiasis, etc.\nLocal infection.\nPregnancy or pregnancy planned within the next 2 years.\nBreastfeeding.\nTreatment with anticoagulants (not interruptible in MO or application).\nAny other illness or condition that is grounds for exclusion for the investigator.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "75 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Lluis Orozco, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "600 421 095",
            "CentralContactEMail": "lluis.orozco@itrt.es"
          },
          {
            "CentralContactName": "Roberto Soler Rich, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "609 525 263",
            "CentralContactEMail": "robert.soler@itrt.es"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Institut de Terapia Regenerativa Tissular",
            "LocationCity": "Barcelona",
            "LocationZip": "08022",
            "LocationCountry": "Spain"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000014987",
            "ConditionMeshTerm": "Xerostomia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012466",
            "ConditionAncestorTerm": "Salivary Gland Diseases"
          },
          {
            "ConditionAncestorId": "D000009059",
            "ConditionAncestorTerm": "Mouth Diseases"
          },
          {
            "ConditionAncestorId": "D000009057",
            "ConditionAncestorTerm": "Stomatognathic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M16876",
            "ConditionBrowseLeafName": "Xerostomia",
            "ConditionBrowseLeafAsFound": "Xerostomia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14437",
            "ConditionBrowseLeafName": "Salivary Gland Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11171",
            "ConditionBrowseLeafName": "Mouth Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11169",
            "ConditionBrowseLeafName": "Stomatognathic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC07",
            "ConditionBrowseBranchName": "Mouth and Tooth Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M3396",
            "InterventionBrowseLeafName": "Anticoagulants",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "AnCoag",
            "InterventionBrowseBranchName": "Anticoagulants"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}